Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease
|
November 16, 2012
Physical inactivity in COPD and increased patient perception of dyspnea
Milla Katajisto, Henna Kupiainen, Piritta Rantanen, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
May 7, 2021
Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD
Rain Jõgi, Leena Mattila, Mikko Vahteristo, et al.
Clinical Physiology and Functional Imaging
|
December 15, 2010
Repeatability of exhaled nitric oxide measurements in patients with COPD
Annamari Rouhos, Annette Kainu, Päivi Piirilä, et al.
COPD
|
January 12, 2016
CHRNA5/CHRNA3 Locus Associates with Increased Mortality among Smokers
Henna Kupiainen, Mikko Kuokkanen, Jukka Kontto, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
February 18, 2011
Overlap syndrome of asthma and COPD predicts low quality of life
Paula Kauppi, Henna Kupiainen, Ari Lindqvist, et al.
Health and Quality of Life Outcomes
|
January 18, 2011
Comparison between the disease-specific Airways Questionnaire 20 and the generic 15D instruments in COPD
Witold Mazur, Henna Kupiainen, Janne Pitkäniemi, et al.
The Journal of Allergy and Clinical Immunology
|
July 9, 2003
Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: a randomized, double-blind, parallel group biopsy study comparing the effects of salmeterol, fluticasone propionate, and disodium cromoglycate
Ari Lindqvist, Eeva-Maija Karjalainen, Lauri A Laitinen, et al.
Pulmonary Pharmacology & Therapeutics
|
February 7, 2012
Effects of an oral MMP-9 and -12 inhibitor, AZD1236, on biomarkers in moderate/severe COPD: a randomised controlled trial
Ronald Dahl, Ingrid Titlestad, Ari Lindqvist, et al.
The Clinical Respiratory Journal
|
March 20, 2010
Atopic sensitization to common allergens without symptoms or signs of airway disorders does not increase exhaled nitric oxide
Annamari Rouhos, Annette Kainu, Jouko Karjalainen, et al.
BMC Pulmonary Medicine
|
June 21, 2014
Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD
Jukka Koskela, Maritta Kilpeläinen, Henna Kupiainen, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
International Journal of Chronic Obstructive Pulmonary Disease
|
November 16, 2012
Physical inactivity in COPD and increased patient perception of dyspnea
Milla Katajisto, Henna Kupiainen, Piritta Rantanen, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
May 7, 2021
Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD
Rain Jõgi, Leena Mattila, Mikko Vahteristo, et al.
Clinical Physiology and Functional Imaging
|
December 15, 2010
Repeatability of exhaled nitric oxide measurements in patients with COPD
Annamari Rouhos, Annette Kainu, Päivi Piirilä, et al.
COPD
|
January 12, 2016
CHRNA5/CHRNA3 Locus Associates with Increased Mortality among Smokers
Henna Kupiainen, Mikko Kuokkanen, Jukka Kontto, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
February 18, 2011
Overlap syndrome of asthma and COPD predicts low quality of life
Paula Kauppi, Henna Kupiainen, Ari Lindqvist, et al.
Health and Quality of Life Outcomes
|
January 18, 2011
Comparison between the disease-specific Airways Questionnaire 20 and the generic 15D instruments in COPD
Witold Mazur, Henna Kupiainen, Janne Pitkäniemi, et al.
The Journal of Allergy and Clinical Immunology
|
July 9, 2003
Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: a randomized, double-blind, parallel group biopsy study comparing the effects of salmeterol, fluticasone propionate, and disodium cromoglycate
Ari Lindqvist, Eeva-Maija Karjalainen, Lauri A Laitinen, et al.
Pulmonary Pharmacology & Therapeutics
|
February 7, 2012
Effects of an oral MMP-9 and -12 inhibitor, AZD1236, on biomarkers in moderate/severe COPD: a randomised controlled trial
Ronald Dahl, Ingrid Titlestad, Ari Lindqvist, et al.
The Clinical Respiratory Journal
|
March 20, 2010
Atopic sensitization to common allergens without symptoms or signs of airway disorders does not increase exhaled nitric oxide
Annamari Rouhos, Annette Kainu, Jouko Karjalainen, et al.
BMC Pulmonary Medicine
|
June 21, 2014
Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD
Jukka Koskela, Maritta Kilpeläinen, Henna Kupiainen, et al.
Page
of 5